Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1996
11/12/1996US5573925 P53 proteins with altered tetramerization domains
11/12/1996US5573924 Novel receptor cytokine, protein
11/12/1996US5573923 Method for removing N-terminal dipeptides from precursor polypeptides with immobilized dipeptidylaminopeptidase from dictyostelium discoideum
11/12/1996US5573918 Process and reagent for specific determination of pancreatic alpha amylase
11/12/1996US5573916 Vaccines, strengthening secondary response to an antigen
11/12/1996US5573915 Determining the ability of a compound to inhibit the cyclopropanation of mycolic acids in pathogenic mycobacteria
11/12/1996US5573910 Alginate production
11/12/1996US5573908 Adrenergic receptor as a proto-oncogene
11/12/1996US5573905 Encoded combinatorial chemical libraries
11/12/1996US5573767 Lutenizing hormone-releasing hormone
11/12/1996US5573766 Application to plants, active against lepidoptera and coleoptera
11/12/1996US5573764 Use of interleukin-12 to prevent graft versus host disease
11/12/1996US5573763 Family of CSF-l proteins
11/12/1996CA2068438C Essential pure human parathyroid hormone
11/12/1996CA1338721C Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
11/12/1996CA1338720C Derivative of human growth hormone
11/12/1996CA1338708C Neisserial vaccines
11/12/1996CA1338707C Protein h being capable of binding to igg, gene coding for the said protein h and a process for producing the said protein h
11/12/1996CA1338705C Vaccines obtained from antigenic gene products of recombinant genes
11/07/1996WO1996034976A1 Methods, nucleotide sequences and host cells for assaying exogenous and endogenous protease activity
11/07/1996WO1996034974A1 Low oxygen affinity mutant hemoglobin
11/07/1996WO1996034966A2 Engineering protein posttranslational modification in transgenic organisms
11/07/1996WO1996034965A2 Chimeric mcp and daf proteins with cell surface localizing domain
11/07/1996WO1996034960A1 High molecular weight major outer membrane protein of moraxella
11/07/1996WO1996034959A1 Aluminium resistance gene
11/07/1996WO1996034958A1 Vasoactive intestinal peptide
11/07/1996WO1996034957A1 Pancreas-derived serpin
11/07/1996WO1996034956A1 Methods for modulating t cell survival by modulating bcl-xl protein level
11/07/1996WO1996034955A1 Method of treating cartilaginous diseases with genetically modified chondrocytes
11/07/1996WO1996034954A2 Biotin-binding containment systems
11/07/1996WO1996034953A2 Cd16-ii variants
11/07/1996WO1996034952A1 Expression of tap and lmp in tumour cells
11/07/1996WO1996034951A1 Gdu, a novel signalling protein
11/07/1996WO1996034949A1 Plant promoter activated by fungal infection
11/07/1996WO1996034942A1 Novel retrovirus and diagnostic methods
11/07/1996WO1996034940A1 Dna encoding glutamate gated chloride channels
11/07/1996WO1996034893A1 Hybrid molecules between heat-labile enterotoxin and cholera toxin b subunits
11/07/1996WO1996034891A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996WO1996034890A2 Inhibitors of fibrin cross-linking and/or transglutaminases
11/07/1996WO1996034889A1 Storage stable hemoglobin solutions
11/07/1996WO1996034888A1 Modulation of cholesteryl ester transfer protein (cetp) activity
11/07/1996WO1996034887A2 Antisense peptides
11/07/1996WO1996034886A1 Compositions and methods for detecting and treating acquired immunodeficiency syndrome
11/07/1996WO1996034885A2 Biologically active peptide fragments of ob protein
11/07/1996WO1996034884A2 Synthetic peptides of m. gallisepticum, antibodies thereto, their preparation and use
11/07/1996WO1996034883A1 Acellular pertussis vaccines and methods of preparation thereof
11/07/1996WO1996034882A1 Single chain insulin with high bioactivity
11/07/1996WO1996034881A1 Peptide compositions with growth factor-like activity
11/07/1996WO1996034880A1 Cd6 ligand
11/07/1996WO1996034879A1 Identification of enantiomeric ligands
11/07/1996WO1996034877A1 Human neuropeptide receptor
11/07/1996WO1996034873A1 Recombinant endotoxin-neutralizing proteins
11/07/1996WO1996034627A1 Murine and human box-dependent myc-interacting protein (bin1) and uses therefor
11/07/1996WO1996034625A1 Recombinant vesiculoviruses and their uses
11/07/1996WO1996034624A1 Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
11/07/1996WO1996034623A1 Acellular pertussis vaccines and methods of preparation thereof
11/07/1996WO1996034622A1 Modified myelin protein molecules
11/07/1996WO1996034619A1 Methods of preventing neuron degeneration and promoting neuron regeneration
11/07/1996WO1996034618A1 Tissue adhesive using synthetic cross-linking
11/07/1996WO1996030520A3 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
11/07/1996WO1996029409A3 Rage tumor rejection antigens
11/07/1996WO1996025507A3 Methods of preparation and use of recombinant adenoviral vectors
11/07/1996WO1996022379A3 Direct gene transfer into the ruminant mammary gland
11/07/1996WO1996015241A3 A polynucleotide tuberculosis vaccine
11/07/1996DE19516040A1 Increasing immune response to tumour cells by increasing expression of TAP or LMP proteins
11/07/1996CA2433502A1 Acellular pertussis vaccines and methods of preparation thereof
11/07/1996CA2231854A1 Novel retrovirus and diagnostic methods
11/07/1996CA2223272A1 Single chain insulin with high bioactivity
11/07/1996CA2220333A1 Plant promoter activated by fungal infection
11/07/1996CA2220268A1 Inhibitors of fibrin cross-linking and/or transglutaminases
11/07/1996CA2220123A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996CA2220109A1 Engineering protein posttranslational modification in transgenic organisms
11/07/1996CA2220098A1 Cd6 ligand
11/07/1996CA2220036A1 Human neuropeptide receptor
11/07/1996CA2220016A1 Gdu, a novel signalling protein
11/07/1996CA2219936A1 Vasoactive intestinal peptide
11/07/1996CA2219889A1 High molecular weight major outer membrane protein of moraxella
11/07/1996CA2219775A1 Murine and human box-dependent myc-interacting protein (bin1) and uses therefor
11/07/1996CA2219020A1 Tissue adhesive using synthetic cross-linking
11/07/1996CA2218858A1 Modified myelin protein molecules
11/07/1996CA2218083A1 Identification of enantiomeric ligands
11/07/1996CA2218034A1 Pancreas-derived serpin
11/07/1996CA2216382A1 Storage stable hemoglobin solutions
11/06/1996EP0741189A1 Process for producing human growth hormone
11/06/1996EP0741188A2 Single chain insulin with high bioactivity
11/06/1996EP0741187A2 Recombinant obese (Ob) proteins
11/06/1996EP0741143A2 Fibroblast growth factor fragments
11/06/1996EP0741142A1 Peptide and antithrombotic agent
11/06/1996EP0741141A2 Method of purifying ologonucleotide from biological samples
11/06/1996EP0740939A1 Compositions for treatment and prophylaxis of atherosclerosis
11/06/1996EP0740792A1 Peptomers with enhanced immunogenicity
11/06/1996EP0740791A1 Systematic modular production of aminimide- and oxazolone-based molecules having selected properties
11/06/1996EP0740708A1 Design of drugs involving receptor-ligand-dna interactions
11/06/1996EP0740707A1 Secretion of proteins from the outer membrane of gram-negative bacteria by gram-positive host organisms
11/06/1996EP0740704A1 Immunization by inoculation of dna transcription unit
11/06/1996EP0740703A1 Diagnosis and treatment of infections due to streptococci and enterococci
11/06/1996EP0740702A1 Novel human amyloid protein precursor homologue and kunitz-type inhibitors
11/06/1996EP0740701A1 Mammalian monocyte chemoattractant protein receptors
11/06/1996EP0740700A1 Natural resistance associated macrophage protein and uses thereof
11/06/1996EP0740699A1 Cell lines, maturation factors and use of said cell lines and factors